Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENT-01 for Parkinson's Disease Related Constipation
NCT03047629Phase 2Completed
- Sponsor
- Enterin Inc.
- Start
- May 2017
- Primary completion
- Apr 2018
- Modality
- Multivalent & Scaffold-Based Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of squalamine in constipation, sponsored by Enterin Inc.. Started May 2017; status: completed.
02
Drugs
squalamine
03
Conditions
constipation
Beyond the preview
Go deeper on NCT03047629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03047629.